Strategic Global Advisors’s Boston Scientific BSX Stock Holding History

Strategic Global Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-14,176	Closed	-$1.19M	–	140
2024 Q3	$1.19M	Buy	+14,176	New	+$1.12M	0.23%	96
2017 Q1	–	Sell	-29,137	Closed	-$630K	–	166
2016 Q4	$630K	Hold	29,137	–	–	0.23%	94
2016 Q3	$681K	Hold	29,137	–	–	0.25%	92
2016 Q2	$681K	Hold	29,137	–	–	0.26%	91
2016 Q1	$548K	Hold	29,137	–	–	0.23%	91
2015 Q4	$537K	Buy	29,137 +5,000	+21%	+$89.6K	0.23%	87
2015 Q3	$396K	Hold	24,137	–	–	0.19%	92
2015 Q2	$427K	Hold	24,137	–	–	0.25%	90
2015 Q1	$428K	Sell	24,137 -21,508	-47%	-$340K	0.32%	82
2014 Q4	$605K	Buy	+45,645	New	+$584K	0.54%	64

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Strategic Global Advisors's BSX Position: Q4 2024 in Review

Strategic Global Advisors sold out of Boston Scientific (BSX) in Q4 2024, closing a stake of 14,176 shares — an estimated $1.19M sold.

Strategic Global Advisors first reported a position in BSX in Q4 2014 and held it in 10 quarters. The position peaked at $1.19M in Q3 2024. 1,521 funds tracked by Wall St. Rank hold BSX as of Q4 2024.

Strategic Global Advisors reported no remaining Boston Scientific position as of Q4 2024 after selling out during the quarter.
Strategic Global Advisors sold 14,176 Boston Scientific shares in Q4 2024, an estimated $1.19M.
Strategic Global Advisors first reported a position in Boston Scientific in Q4 2014 and held it in 10 quarters.
Strategic Global Advisors's Boston Scientific position peaked at $1.19M in Q3 2024.
1,521 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2024.

Based on Strategic Global Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.